Brandon Hanley

Commercial Litigation

• Representing Gem Realty Capital in a breach of contract dispute in Delaware state court.
• Representing Teva Pharmaceuticals in litigation alleging breach of an asset purchase agreement and letter of intent relating to generic Rotigotine products sold under the brand name Neupro®.

Securities Litigation

• Representing Target Corporation and certain of its officers and directors, defending a securities action filed in Florida federal court arising out of Target’s 2023 LGBTQ+ Pride campaign and other DEI and ESG initiatives.
• Representing Target Corporation and certain of its officers and directors, defending a putative securities class action filed in Minnesota federal court, arising out of Target’s inventory management during the COVID-19 pandemic.

Antitrust Litigation

• Representing Gilead Sciences, Inc. in a multidistrict litigation alleging anticompetitive conduct concerning a range of pharmaceutical products. 
• Representing a pharmaceutical company in California state litigation alleging an anti-competitive reverse payment arising out of a patent settlement concerning anti-diabetic medication.
• Represented Sun Pharmaceuticals in West Virginia state action alleging an anti-competitive reverse payment arising out of a patent settlement concerning Lipitor (atorvastatin).